Concepedia

Publication | Closed Access

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

DOI

62

Citations

19

References

2011

Year

Sarah F. Adams, Evelyn B. Marsh, Wafic M. ElMasri, Steffanie M. Halberstadt, Stephanie VanDecker, Mary D. Sammel, Angela R. Bradbury, Mary B. Daly, Beth Y. Karlan, Stephen C. Rubin
Gynecologic Oncology

References

YearCitations

Page 1